Transitional Drugs 5
Details
| Contract Title: | Transitional Drugs 5 |
| Published Date: | Dec 9, 2025 |
| Notice Type: | Award (ContractAwardNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
The provision of drugs that have recently lost exclusivity, namely Aflibercept; Dapagliflozin; Golimumab...
